GoHealth Q2 2024 GAAP EPS $(2.70) Misses $(2.57) Estimate, Sales $105.870M Miss $141.792M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoHealth reported its Q2 2024 financial results, with a GAAP EPS of $(2.70), missing the estimate of $(2.57). Sales were $105.870 million, falling short of the $141.792 million estimate.
August 08, 2024 | 10:02 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GoHealth's Q2 2024 financial results were disappointing, with both GAAP EPS and sales missing estimates. This could negatively impact the stock price in the short term.
The significant miss on both earnings and sales estimates suggests operational challenges and could lead to a negative market reaction. Investors may lose confidence, leading to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100